Literature DB >> 18588928

Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis.

Julia M Martínez Gómez1, Noémi Csaba, Stefan Fischer, Anke Sichelstiel, Thomas M Kündig, Bruno Gander, Pål Johansen.   

Abstract

Surface modifications of poly(lactide-co-glycolide) microparticles with different polycationic electrolytes have mainly been studied for conjugation to antigens and/or adjuvants. However, the in vivo immunological effects of using surface charged particles have not been address yet. In this study, microparticles were coated or not with protamine, a cationic and arginine-rich electrolyte that confers microparticles with a positively surface charge. We then evaluated the potential of protamine-coatings to assist the induction of immune responses in mice. Interestingly, enhanced antibodies and T-cell responses were observed in mice treated with the coated particles. In vitro studies suggested that the improved immunological performance was mediated by an increased uptake. Indeed, protamine-coated particles that carried a plasmid were even internalised into non-phagocytic cells and to cause their transfection. These results open the way for further research into a novel technology that combines the use protamine for facilitated cell penetration of that and biodegradable microparticles for prolonged antigen or drug release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588928     DOI: 10.1016/j.jconrel.2008.06.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

Review 1.  Peptide/protein vaccine delivery system based on PLGA particles.

Authors:  Mojgan Allahyari; Elham Mohit
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Presentation Modality of Glycoconjugates Modulates Dendritic Cell Phenotype.

Authors:  N A Hotaling; D M Ratner; R D Cummings; J E Babensee
Journal:  Biomater Sci       Date:  2014-10-01       Impact factor: 6.843

Review 3.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

4.  Delivery of rapamycin to dendritic cells using degradable microparticles.

Authors:  S Jhunjhunwala; G Raimondi; A W Thomson; S R Little
Journal:  J Control Release       Date:  2008-10-26       Impact factor: 9.776

5.  Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo.

Authors:  Li Luo; Tao Qin; Yifan Huang; Sisi Zheng; Ruonan Bo; Zhenguang Liu; Jie Xing; Yuanliang Hu; Jiaguo Liu; Deyun Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.

Authors:  Sai-Nan He; Yun-Long Li; Jing-Jing Yan; Wei Zhang; Yong-Zhong Du; He-Yong Yu; Fu-Qiang Hu; Hong Yuan
Journal:  Int J Nanomedicine       Date:  2013-08-07

Review 7.  PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.

Authors:  A L Silva; P C Soema; B Slütter; F Ossendorp; W Jiskoot
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

8.  Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases.

Authors:  Christopher J Genito; Cole J Batty; Eric M Bachelder; Kristy M Ainslie
Journal:  Adv Nanobiomed Res       Date:  2021-01-18

9.  Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.

Authors:  Chanyoung Song; Young-Woock Noh; Yong Taik Lim
Journal:  Int J Nanomedicine       Date:  2016-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.